Neonatal-Onset Multisystem Inflammatory Disease (NOMID)
Also known as: Neonatal Onset Multisystem Inflammatory Disease / NOMID / CINCA Syndrome / Neonatal-onset multisystem inflammatory disease / Neonatal-onset multisystemic inflammatory disease / Cryopyrin-associated periodic syndromes / Chronic infantile neurological cutaneous and articular syndrome / Chronic infantile neurological, cutaneous and articular syndrome (disorder) / Chronic Infantile Neurological, Cutaneous, and Articular Syndrome
Drug | Drug Name | Drug Description |
---|---|---|
DB00026 | Anakinra | A recombinant form of human interleukin-1 receptor antagonist used in the treatment of rheumatoid arthritis, neonatal-onset multisystem inflammatory disease and deficiency of interleukin-1 receptor antagonist (DIRA). |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB00026 | Anakinra | Interleukin-1 receptor type 1 | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB06168 | Canakinumab | 3 | Completed | 4 |
DB06168 | Canakinumab | 3 | Terminated | 1 |